SOURCE: Bio Stem, Inc.

March 20, 2007 09:48 ET

Cryobanks International Featured in Daytona Beach News Journal Article

ATLANTA, GA -- (MARKET WIRE) -- March 20, 2007 -- Bio Stem, Inc. (OTCBB: BTEM) announced today that Cryobanks International, Inc., which has agreed to be acquired by Bio Stem, Inc., released the following announcement:

In an article entitled "Umbilical Cord Cells Offer Hope," the Sunday, March 18th edition of the Daytona Beach News Journal ( ) discusses the option to donate or store umbilical cord blood. New parents are faced with a barrage of information regarding their choices, however, the decision on what to do can be confusing considering everything else surrounding the arrival of a newborn child.

In the article, it was noted that Cryobanks International is the only facility where expectant parents can donate their child's cord blood from anywhere in the continental United States year round. The donated units are placed on international registries, including the National Marrow Donor Program, where anyone in need of a potential life saving transplant can access them.

About Cryobanks:

Cryobanks International, is a corporation located in Altamonte Springs, FL. The Company is a leader in the collection, processing, and banking of stem cells derived from the umbilical cord immediately after birth. The units of cord blood (CB) are processed and stored by the company for use in unrelated transplants (where the donor is a histocompatible match, but is anonymous and unrelated to the recipient) and for personal storage and use. In recent years, cord blood transplants (CBTs) have become widely recognized as a safe, effective, and in many ways preferable, alternative to bone marrow transplant (BMT). There is tremendous potential need for CBTs in the United States and worldwide. Cryobanks International is well poised to help meet that need, equipped with an inventory of over 9,000 cord blood units. For more information about Cryobanks International call 1-800-869-8608 or visit the website at

Safe Harbor Statement

This press release contains "forward-looking statements" by the Company. These statements relate to future events or financial performance and transactions, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements, to be materially different from those contemplated by the forward-looking statements. We undertake no ongoing obligation, other than that imposed by law, to update these statements.

Contact Information

  • Contact:
    Marc Ebersole
    Bio Stem, Inc.
    200 Hannover Park Road
    Suite 120
    Atlanta, GA
    Email Contact